Oceanpine Capital leads $73m funding in US biopharma firm Immune-Onc

Oceanpine Capital leads $73m funding in US biopharma firm Immune-Onc

Immune-Onc Therapeutics, a California-based cancer immunotherapy firm co-founded by Chinese pharma specialist Charlene Liao, has raised $73 million in Series B1 and B2 rounds of financing, it announced earlier this week.